Stock ALCLS CELLECTIS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

All News Cellectis S.A.

Equities

ALCLS

FR0010425595

Market Closed - Euronext Paris
Other stock markets
 11:35:14 2024-05-10 am EDT 		5-day change 1st Jan Change
2.835 EUR +0.53% Intraday chart for Cellectis S.A. +2.72% +2.57%
May. 10 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3% MT
May. 07 Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%
MT
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday
MT
Cellectis S A : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
PU
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
MT
Cellectis: alliance with AstraZeneca finalized
CF
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca
MT
AstraZeneca: equity investment in Cellectis
CF
AstraZeneca completes collaboration and investment deal with Cellectis
AN
AstraZeneca Secures 44% Stake in French Biotech Cellectis
MT
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GL
Cellectis S.A. announced that it has received $140 million in funding from AstraZeneca PLC
CI
Cellectis CFO Bing Wang Retires, Interim CFO Appointed
MT
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
GL
Cellectis Announces Chief Financial Officer Changes
CI
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading
MT
Cellectis S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
GL
Cellectis S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALCLS Stock
  4. News Cellectis S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW